Lina Nilsson is Senior Director of Data Science Product at Recursion Pharmaceuticals, a company that is reimagining drug discovery through machine learning and large-scale experiment automation. Previously, she was the COO of Enlitic, a startup that uses deep learning to improve clinical diagnostics in medical imaging. As Innovation Director at University of California, Berkeley, she helped scale and spin out new social-impact technologies. Lina has also been recognized on MIT Technology Review's "TR35" annual list of the world's top innovators for her work in open science. Her writings on open science, social impact and technology, and gender and tech have been published in the New York Times, Washington Post, Science, and Make Magazine. Lina has a PhD in biomedical engineering from the ETH Zurich.